These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30535006)

  • 1. Combined checkpoint inhibitor-associated myocarditis and pulmonary vasculitis mimicking acute pulmonary embolism.
    Baldetti L; Melillo F; Beneduce A; Camici PG
    Eur Heart J Cardiovasc Imaging; 2019 Feb; 20(2):243. PubMed ID: 30535006
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe myocarditis with slight lymphocytic infiltration after nivolumab treatment.
    Edahiro R; Shiroyama T; Hijiki S; Nojima S; Shirai Y; Koyama S; Kumanogoh A
    Lung Cancer; 2020 Feb; 140():116-117. PubMed ID: 31848027
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune checkpoint inhibitors myocarditis: not all cases are clinically patent.
    Thibault C; Vano Y; Soulat G; Mirabel M
    Eur Heart J; 2018 Oct; 39(38):3553. PubMed ID: 30107497
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fulminant myocarditis caused by nivolumab treatment for non-small cell lung cancer (NSCLC): a case report].
    Tan KX; Li CY; Zhang JY; Cui HJ; Shen W; Zhang X; Sun CY; Jiang XJ; Zheng SY; Li J; Xue CX
    Zhonghua Zhong Liu Za Zhi; 2020 Dec; 42(12):1047-1048. PubMed ID: 33342162
    [No Abstract]   [Full Text] [Related]  

  • 5. Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation.
    Valenti-Azcarate R; Esparragosa Vazquez I; Toledano Illan C; Idoate Gastearena MA; Gállego Pérez-Larraya J
    Neuromuscul Disord; 2020 Jan; 30(1):67-69. PubMed ID: 31839404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulminant Myocarditis Caused by an Immune Checkpoint Inhibitor: A Case Report With Pathologic Findings.
    Imai R; Ono M; Nishimura N; Suzuki K; Komiyama N; Tamura T
    J Thorac Oncol; 2019 Feb; 14(2):e36-e38. PubMed ID: 30391574
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy- A double Edged Sword; A case of Fatal Myocarditis and Complete Response.
    Peters N; Greally M; Breen K; Fabre A; Blazkova S
    Ir Med J; 2019 May; 112(5):937. PubMed ID: 31411390
    [No Abstract]   [Full Text] [Related]  

  • 8. Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis.
    Salem JE; Allenbach Y; Vozy A; Brechot N; Johnson DB; Moslehi JJ; Kerneis M
    N Engl J Med; 2019 Jun; 380(24):2377-2379. PubMed ID: 31189043
    [No Abstract]   [Full Text] [Related]  

  • 9. Case 30-2019: A 65-Year-Old Woman with Lung Cancer and Chest Pain.
    Guiney TE; Lopes MS; Kalra MK; Mooradian MJ; Neilan TG; Stone JR
    N Engl J Med; 2019 Sep; 381(13):1268-1277. PubMed ID: 31553841
    [No Abstract]   [Full Text] [Related]  

  • 10. [Third degree atrio-ventricular blockade during a myocarditis occurring under anti-PD1 : Case report and literature review].
    Prevel R; Colin G; Calès V; Renault PA; Mazieres J
    Rev Med Interne; 2020 Apr; 41(4):284-288. PubMed ID: 31983550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report.
    Monge C; Maeng H; Brofferio A; Apolo AB; Sathya B; Arai AE; Gulley JL; Bilusic M
    J Immunother Cancer; 2018 Dec; 6(1):150. PubMed ID: 30563577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding.
    Dall'Olio FG; Sperandi F; Rihawi K; Gargiulo M; Melotti B; Brocchi S; Gelsomino F; Ardizzoni A
    J Thorac Oncol; 2018 Dec; 13(12):e247-e248. PubMed ID: 30467045
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal association of fulminant myocarditis and rhabdomyolysis after immune checkpoint blockade.
    Tomoaia R; Beyer RȘ; Pop D; Minciună IA; Dădârlat-Pop A
    Eur J Cancer; 2020 Jun; 132():224-227. PubMed ID: 32336614
    [No Abstract]   [Full Text] [Related]  

  • 14. Nivolumab-induced Pancreatitis: An Immune-related Adverse Event.
    Saito H; Ono K
    Radiology; 2019 Dec; 293(3):521. PubMed ID: 31617817
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-PD1 therapy-associated cutaneous leucocytoclastic vasculitis: A case series.
    Tomelleri A; Campochiaro C; De Luca G; Cavalli G; Dagna L
    Eur J Intern Med; 2018 Nov; 57():e11-e12. PubMed ID: 30076088
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-induced myocarditis after nivolumab treatment in a patient with PDL1- negative squamous cell carcinoma of the lung.
    Semper H; Muehlberg F; Schulz-Menger J; Allewelt M; Grohé C
    Lung Cancer; 2016 Sep; 99():117-9. PubMed ID: 27565924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1 inhibitor-associated severe myasthenia gravis with necrotizing myopathy and myocarditis.
    So H; Ikeguchi R; Kobayashi M; Suzuki M; Shimizu Y; Kitagawa K
    J Neurol Sci; 2019 Apr; 399():97-100. PubMed ID: 30798111
    [No Abstract]   [Full Text] [Related]  

  • 18. Nivolumab-associated myositis myocarditis and myasthenia and anti-striated muscle antibodies.
    Fazal M; Prentice DA; Kho LK; Fysh E
    Intern Med J; 2020 Aug; 50(8):1003-1006. PubMed ID: 33306231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Not Available].
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(4):263b. PubMed ID: 29176295
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatal myocarditis and rhabdomyolysis induced by nivolumab during the treatment of type B3 thymoma.
    Chen Q; Huang DS; Zhang LW; Li YQ; Wang HW; Liu HB
    Clin Toxicol (Phila); 2018 Jul; 56(7):667-671. PubMed ID: 29126352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.